Field & Main Bank Abb Vie Inc. Transaction History

Field & Main Bank

$278 Million
Q3 2024

A detailed history of Field & Main Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Field & Main Bank holds 11,350 shares of ABBV stock, worth $2.03 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares

11,350

Previous 11,650 2.58%

Holding current value

$2.03 Million

Previous $2 Million 12.16%

% of portfolio

0.81%

Previous 0.76%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$163.84 - $199.33 $49,152 - $59,799	-300 Reduced 2.58%	11,350 $2.24 Million
Q2 2024 Jul 25, 2024	BUY	$154.79 - $180.76 $4,024 - $4,699	26 Added 0.22%	11,650 $2 Million
Q1 2024 Apr 29, 2024	SELL	$159.82 - $182.1 $155,185 - $176,819	-971 Reduced 7.71%	11,624 $2.12 Million
Q4 2023 Feb 05, 2024	SELL	$137.6 - $154.97 $60,131 - $67,721	-437 Reduced 3.35%	12,595 $1.95 Million
Q3 2023 Oct 12, 2023	SELL	$133.59 - $154.65 $69,867 - $80,881	-523 Reduced 3.86%	13,032 $1.94 Million
Q2 2023 Jul 26, 2023	SELL	$132.51 - $164.9 $20,539 - $25,559	-155 Reduced 1.13%	13,555 $1.83 Million
Q1 2023 Apr 19, 2023	SELL	$144.61 - $166.54 $32,537 - $37,471	-225 Reduced 1.61%	13,710 $2.18 Million
Q4 2022 Jan 19, 2023	SELL	$138.31 - $165.87 $45,503 - $54,571	-329 Reduced 2.31%	13,935 $0
Q3 2022 Oct 25, 2022	SELL	$134.21 - $153.93 $12,078 - $13,853	-90 Reduced 0.63%	14,264 $1.92 Million
Q2 2022 Jul 18, 2022	SELL	$137.62 - $174.96 $29,037 - $36,916	-211 Reduced 1.45%	14,354 $2.2 Million
Q1 2022 Apr 21, 2022	SELL	$131.98 - $163.75 $48,832 - $60,587	-370 Reduced 2.48%	14,565 $2.36 Million
Q4 2021 Feb 01, 2022	BUY	$107.43 - $135.93 $44,046 - $55,731	410 Added 2.82%	14,935 $2.02 Million
Q3 2021 Oct 14, 2021	SELL	$106.4 - $120.78 $532 - $603	-5 Reduced 0.03%	14,525 $1.57 Million
Q2 2021 Jul 15, 2021	BUY	$105.21 - $117.21 $45,766 - $50,986	435 Added 3.09%	14,530 $1.64 Million
Q1 2021 Apr 30, 2021	BUY	$102.3 - $112.62 $47,569 - $52,368	465 Added 3.41%	14,095 $1.53 Million
Q4 2020 Feb 25, 2021	SELL	$80.49 - $108.67 $5,634 - $7,606	-70 Reduced 0.51%	13,630 $1.46 Million
Q3 2020 Oct 22, 2020	BUY	$85.91 - $100.83 $303,262 - $355,929	3,530 Added 34.71%	13,700 $1.2 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $54,660 - $73,144	745 Added 7.9%	10,170 $998,000
Q4 2019 Feb 03, 2020	SELL	$72.13 - $90.25 $16,229 - $20,306	-225 Reduced 2.33%	9,425 $835,000
Q3 2019 Nov 07, 2019	SELL	$62.98 - $75.72 $101,397 - $121,909	-1,610 Reduced 14.3%	9,650 $731,000
Q2 2019 Jul 22, 2019	SELL	$65.7 - $83.98 $1,642 - $2,099	-25 Reduced 0.22%	11,260 $818,000
Q1 2019 Apr 24, 2019	SELL	$77.14 - $90.79 $42,041 - $49,480	-545 Reduced 4.61%	11,285 $909,000
Q3 2018 Oct 23, 2018	BUY	$88.91 - $98.84 $17,782 - $19,768	200 Added 1.72%	11,830 $1.12 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $54,316 - $64,269	605 Added 5.49%	11,630 $1.07 Million
Q1 2018 May 01, 2018	BUY	$92.01 - $123.21 $131,114 - $175,574	1,425 Added 14.84%	11,025 $0
Q4 2017 Jan 24, 2018	BUY	$89.56 - $98.21 $859,776 - $942,815	9,600	9,600 $928,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Field & Main Bank, based on Form 13F filings with the SEC.

News

Stay updated on Field & Main Bank with notifications on news.

Account